Clinical Trials

30 enrolled

Phase EARLY_PHASE1 Not yet recruiting

CDH17-positive Advanced Solid Tumors

NCT06713148 2025-02-06

Study on the Safety and Efficacy of Intratumoral Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors

42 enrolled

Advanced Malignant Solid Tumor

NCT06718946 2025-02-06

Study on the Safety and Efficacy of Intravenous Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors

38 enrolled

Advanced Malignant Solid Tumor

NCT06026605 2025-01-16

A Dose Escalation and Dose Expansion Trial of WTX212A in the Treatment of Patients with Advanced Malignant Tumors

44 enrolled

Unresectable or Metastatic Advanced Solid Tumors

NCT05346692 2025-01-14

Digital Meditation for Postoperative Pain Control After Abdominal Surgery for Cancer

73 enrolled

Phase EARLY_PHASE1 Terminated

Hematopoietic and Lymphoid System Neoplasm

NCT02748798 2024-10-15

Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders

10 enrolled

Asbestosis, Asthma, Bronchiectasis, Cystic Fibrosis, Emphysema, Rhinitis, Allergic, Seasonal, Hypertension, Pulmonary, Lung Neoplasms, Mesothelioma, Pulmonary Embolism, Pulmonary Fibrosis, Lung Diseases, Interstitial, Sleep Apnea, Obstructive, Pulmonary Disease, Chronic Obstructive

NCT06515626 2024-09-25

Genetically Modified T Cells Treating Malignant Tumors

100 enrolled

Solid Tumor

NCT05831033 2024-09-19

Safety and Efficacy of an Autologous Tumor Infiltrating Lymphocyte (TIL) Therapy in Patients with Advanced Solid Tumors

16 enrolled

Phase EARLY_PHASE1 Withdrawn

Solid Tumor

NCT05515692 2024-07-23

Electron Beam Radiotherapy for the Treatment of Refractory Sclerodermatous Chronic Graft Versus Host Disease

OtherOther solid neoplasm

Hematopoietic and Lymphoid System Neoplasm

NCT05579275 2024-05-14

Evaluate the Safety and Tolerability of JCXH-212 Monotherapy and Combined With Toripalimab in the Treatment of Malignant Solid Tumors

Phase EARLY_PHASE1 Withdrawn

Malignant Solid Tumors

NCT03905538 2024-03-01

Evaluation of [18F]FLT PET/CT as an Early Predictor of Outcome in Pediatric Solid Tumors

Solid Tumor

NCT04552418 2024-02-28

Intestinal Microbiome Modification With Resistant Starch in Patients Treated With Dual Immune Checkpoint Inhibitors

12 enrolled

Solid Tumor

NCT05724732 2023-02-13

Exploratory Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Gynecologic Tumors

Solid Tumor

NCT05638828 2022-12-06

A Study of RD14-01 in Patients With Advanced Solid Tumors

Solid Tumor

NCT05623891 2022-11-23

Safety Study of 177Lu-Anti-ED-B mAbs SPECT Imaging in Patients With ED-B Positive Solid Tumors

10 enrolled

Solid Tumor, Adult

NCT05137275 2022-10-27

Study of Anti-5T4 CAR-raNK Cell Therapy in Locally Advanced or Metastatic Solid Tumors

56 enrolled

Locally Advanced or Metastatic Solid Tumors

NCT05373147 2022-10-26

αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors

21 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Solid Tumor

NCT05539768 2022-09-14

Study on the Safety and Efficacy of Autogenous Tumor Infiltrates Lymphocytes for the Treatment of Advanced Solid Tumor

8 enrolled

Advanced Solid Tumor

NCT05515185 2022-08-25

B7-H3 Targeting CAR-T Cells Therapy for B7-H3 Positive Solid Tumors

30 enrolled

Advanced Solid Tumor

NCT05382377 2022-05-19

NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors

18 enrolled

CRC

NCT05284968 2022-03-17

RD07 Cell Injection in the Treatment of Patients With Advanced Claudin18.2 Positive Solid Tumors

36 enrolled

Solid Tumor

NCT05194709 2022-02-02

Study of Anti-5T4 CAR-NK Cell Therapy in Advanced Solid Tumors

40 enrolled

Advanced Solid Tumors

NCT05166070 2021-12-21

An Exploratory Clinical Study of RD133 in Subjects With Relapsed or Refractory MSLN-Positive Solid Tumors

Phase EARLY_PHASE1 Terminated

Solid Tumor

NCT01466855 2020-09-14

IARB1

36 enrolled

Retinoblastoma

NCT04489862 2020-07-28

αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors

10 enrolled

Carcinoma, Non-Small-Cell Lung, Mesothelioma

NCT04056026 2019-09-23

A Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic Mesothelioma

1 enrolled

Mesothelioma

NCT01722149 2019-08-07

Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma

4 enrolled